AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Program
  • Media Gallery
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Program
  • Media Gallery
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Apr 07, 2023

When it looks and itches like atopic dermatitis. But isn’t.

Additional steps and investigation can assist in diagnosis.


Session Director Raj Chovatiya, MD, PhD, FAAD
Session Director Raj Chovatiya, MD, PhD, FAAD

F088 – Itch Tales: The Challenges of Diagnosing Atopic Dermatitis

Atopic dermatitis is one of the most common diagnoses in dermatology, and with good reason. Much of the time, the diagnosis really is that simple — except for those times when things aren’t as they appear.

There are multiple other inflammatory, autoimmune, and systemic disorders that can present in much the same way as AD, and knowing when to look beyond that initial diagnosis can be the key to getting the best outcome for your patients.

Making the distinction between AD and another condition often comes down to the two greatest tools used by dermatologists: patient history and physical exams, said Raj Chovatiya, MD, PhD, FAAD, director of the Center for Eczema and Itch and medical director of the Clinical Trials Unit, and assistant professor of dermatology at the Northwestern University Feinberg School of Medicine in Chicago, during the March 19 session, “Itch Tales: The Challenges of Diagnosing Atopic Dermatitis.” 

“Atopic dermatitis is a clinical diagnosis (as are many other mimickers), meaning that biopsy, laboratory testing, or imaging are not necessary for making the diagnosis,” he said. “A detailed history with the right questions can make a big difference along with an appreciation for nuanced findings on the skin. However, in difficult cases, careful use of additional diagnostics can make all the difference when it comes to including and excluding the right dermatoses on the differential diagnosis.”

Searching beneath the surface

Even something as seemingly simple as diaper dermatitis can present as AD.

Peter Lio, MD, FAAD, clinical assistant professor of dermatology and pediatrics at the Northwestern University Feinberg School of Medicine in Chicago, said he has seen many cases of patients with rashes in the diaper area that mimicked AD.         

Peter Lio, MD, FAADPeter Lio, MD, FAAD“I think the issue is that because AD is so common, and because it is heterogeneous, it can become something of a ‘wastebasket diagnosis’ in some situations,” he said. “By that I mean, if it is even remotely eczematous but it’s not entirely clear what it is, it may be easier to just call it AD and start treatment. Eczematous dermatitis — comprising AD, seborrheic dermatitis, nutritional deficiencies, and other rashes that are red, scaly, and sometimes oozing or weeping — can be confusing.”

Dr. Lio said in one particular case of diaper dermatitis, the real culprit came from a surprising place. “For that case, we noted the presence of Koebnerization,” he said. “It was appearing in areas that had been scratched. This is not typical of AD, but it is sometimes seen in nutritional deficiencies. This prompted a review of (the patient’s) total parenteral nutrition, and it was found that zinc was being accidentally omitted. With zinc added back, everything cleared up within a few days. It was remarkable.”

Take the time you need to diagnose

JiaDe (Jeff) Yu, MD, MS, FAAD, assistant professor of dermatology and director of contact and occupational dermatitis at Massachusetts General Hospital in Boston, said he encountered a case of an 8-month-old baby who reportedly had a history of AD since birth as well as a history in the family. But after initial treatments didn’t work, a little more digging was necessary.JiaDe (Jeff) Yu, MD, MS, FAADJiaDe (Jeff) Yu, MD, MS, FAAD

“He failed to improve with topical steroids and needed repeated systemic steroids for improvement,” Dr. Yu said. “This is not typical for AD and should prompt consideration for another etiology. He was checked for viral and bacterial infection, which were all negative. Ultimately, he made it to me for patch testing — the gold standard for evaluation of allergic contact dermatitis. We found several relevant positive reactions in the products being used to treat his dermatitis, including the topical steroids. Avoidance led to significant improvement.”

Ultimately, Dr. Chovatiya said, it comes down to taking the time to make the right diagnosis.

“We’re living through the greatest era of AD research, and we finally have safe, targeted options for our patients, with many more to come,” he said. “However, the right therapies only work for the right diagnosis. If you treat incorrectly, your patients aren’t going to get better, and you may create new problems. Although AD is common, every single patient with inflamed skin, eczematous changes, and pruritus does not have AD. Always keep a broad perspective before homing in on the diagnosis.”

Other presenters included Joaquin C. Brieva, MD, FAAD, Joan Guitart, MD, George Han, MD, PhD, FAAD, Theodore Rosen, MD, FAAD, and Elizabeth A. Swanson, MD, FAAD.

Visit AAD DermWorld Meeting News Central for more articles.

Interesting Stories
Janssen-Sponsored Symposium
Presented by Janssen Biotech, Inc.
Janssen-Sponsored Symposium
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
Advancing Therapeutic Conversations
Presented by AbbVie
Advancing Therapeutic Conversations
Join Us to Learn More About SOTYKTU<sup>TM</sup> (deucravacitinib):
Presented by Bristol Myers Squibb
Join Us to Learn More About SOTYKTUTM (deucravacitinib):
Prurigo Nodularis and Atopic Dermatitis:
Presented by Sanofi and Regeneron Pharmaceuticals, Inc.
Prurigo Nodularis and Atopic Dermatitis:
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Presented by Pfizer Inc.
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Presented by Neutrogena
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
More in AAD 2023 Annual Meeting
Left to right: Kelly Tyler, MD, FAAD, and Howa Yeung, MD, FAAD
AAD 2023 Annual Meeting
Lifting the veil
Apr 07, 2023
Session director Trilokraj Tejasvi, MD, MBBS
AAD 2023 Annual Meeting
Decoding the benefits and burdens of technology in dermatology
Apr 07, 2023
Left to right: Rebecca I. Hartman, MD, MPH, FAAD, Abigail Baird Waldman, MD, FAAD, and Emily S. Ruiz, MD, FAAD.
AAD 2023 Annual Meeting
Surgery is not the only option for skin cancers
Apr 07, 2023
Terrence A. Cronin Jr., MD, FAAD
AAD 2023 Annual Meeting
From 17 to 20,000: New president accepts challenge of Academy’s 85-year growth
Apr 07, 2023
Left to right: Maria Aleshin, MD, FAAD, and Silvina Pugliese, MD, FAAD
AAD 2023 Annual Meeting
Beyond the familiar
Apr 07, 2023
Safi Bahcall
AAD 2023 Annual Meeting
Nurture the unexpected
Mar 20, 2023
Richard L. Gallo, MD, PhD, FAAD
AAD 2023 Annual Meeting
New approach uses microbiome to treat skin disease
Mar 20, 2023
Camp Discovery 92
AAD 2023 Annual Meeting
Refer a patient to Camp Discovery!
Mar 20, 2023
Amy J. McMichael, MD, FAAD
AAD 2023 Annual Meeting
A question of belonging
Mar 20, 2023
David J. Margolis, MD, PhD, FAAD
AAD 2023 Annual Meeting
Dermatologists top the list in antibiotic prescriptions
Mar 20, 2023
22 698 Ia23 Web Card 3x2
AAD 2023 Annual Meeting
Mark your calendar for Innovation Academy 2023
Join the learning
Mar 20, 2023
Getty Images 479036574
AAD 2023 Annual Meeting
Save the date for the 2024 Annual Meeting
Mark your calendar for AM2024
Mar 20, 2023
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.